The biological substrate of eating disorders

Current Opinion in Psychiatry

Volumn 10, Issue 4, 1997, Pages 296-299

  Kearfott Hill, Kelly S ^a,b   Hill, Daniell B ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; CATECHOLAMINE;

ANOREXIA NERVOSA; BULIMIA; FEEDING BEHAVIOR; FEEDING DISORDER; HUMAN; IMAGING; MORBIDITY; MORTALITY; NEUROPATHOLOGY; PATIENT CARE; PSYCHOLOGICAL ASPECT; RELAPSE; SEROTONINERGIC SYSTEM; SHORT SURVEY;

EID: 0030816602     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-199707000-00008     Document Type: Short Survey

References (25)

1. Ericsson M, Poston WS 2nd, Foreyt JP: Common biological pathways in eating disorders and obesity. Addictive Behav 1996, 21:733-743 An excellent review summarizing knowledge of the neurotransmitter systems and their potential role in the pathophysiology of eating disorders.
2. Kaye WH, Ebert MH, Raleigh M, Lake CR: Abnormalities in CNS monoamine metabolism in anorexia nervosa. Arch Gen Psychiatry 1984, 41:350-352.
3. Kaye WH, Gwirtsman HE, Gearge DT, Ebert MH: Altered serotonin activity in anorexia nervosa after long-term weight restoration: does elevated CSF-5HIAA correlate with rigid and obsessive behavior? Biol Psychiatry 1991, 48:556-562.
4. Brewerton TD: Toward a unified theory of serotonin disturbances in eating and related disorders. Psychoneuroimmunology 1995, 20:561-590.
5. Jimerson DC, Lesem N, Kaye WH, Brewerton TD: Low serotonin and dopamine metabolite concentrations in cerebral spinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry 1992, 49:132-138.
6. Bjorntorp P: Neuroendocrine abnormalities in human obesity. Metabolism 1995, 44(Suppl):38-41.
7. Brambilla F, Ferrari E, Panerai A, Manfredi B, Petraglia F, Catalano M, Sacerdote P: Psychoimmunoendocrine investigation of anorexia nervosa. Neuropsychobiology 1993, 27:9-16.
8. Kaye WH: Neuropeptide abnormalities. In Psychobiology and treatment of anorexia nervosa and bulimia nervosa. Edited by Halmi KA. Washington DC: American Psychiatric Press; 1992:169-191.
9. Hubner HF: Endorphins, eating disorders, and other addictive behaviors. New York: WW Norton and Company; 1993.
10. Brambilla F, Brunetta M, Peirone A, Manzotti A, Sacerdote P, Panerai AE: Lymphocyte concentrations of beta-endorphin-8 in anorexia and bulimia nervosa. In Primary and secondary eating disorders: a psychoneuroendocrine and metabolic approach. Edited by Ferrari E, Brambilla F, Solerte SB. Oxford, UK: Pergamon Press; 1993:167-174.
11. Brewerton TD, Lydiard RB, Laraia MT, Shook JE, Ballenger JC: CSF Beta-endorphin in bulimia nervosa. Am J Psychiatry 1992, 149:1086-1090.
12. Demitrack MA, Putnam FW, Rubinow DR, Pigott TA, Altemus, M, Krahn DD, Gold PW: Relation of dissociative phenomena to levels of cerebrospinal fluid monoamine metabolites and beta-endorphin in patients with eating disorders: a pilot study. Psychiatry Res 1993, 49:1-10.
13. Brunani A, Invitti C, Dubini A, Piccoletti R, Bendinelli P, Maroni P, Pezzoli G, Ramella G, Calogero A, Cavagnini F: Cerebrospinal fluid and plasma concentrations of SRIH, beta-endorphin, CRH, NPY, and GRRH in obese and normal weight subjects. Int J Obesity 1995, 19:17-21.
14. Zumoff B: Hormonal abnormalities in obesity: cause or effect? In Obesity: new directions in assessment and management. Edited by Vanltallie TB, Simonpoulos AP, Gullo SP, Futterweit W. Philadelphia, PA: The Charles Press; 1995:40-65.
15. Krieg JC: Eating disorders as assessed by cranial computerized tomography. Adv Exp Med Biol 1991, 291:223-229.
16. Golden NH, Ashtaro M, Kohn MR, Patel M, Jacobson MS, Fletcher A, Shenker IR: Reversibility of cerebral ventricular enlargement in anorexia nervosa, demonstrated by quantitative magnetic resonance imaging. J Pediatr 1996, 128:296-301.
17. Delvenne V, Lostra F, Goldman S, Biver F, De Maertelaer V, Appelboom-Fondu J, Schoutens A, Bidaut LM, Luxen A, Mendelwicz J: Brain hypometabolism of glucose in anorexia nervosa: a PET scan study. Biol Psychiatry 1995, 37:161-169.
18. Krieg JC, Holtholl V, Schreiber W, Pirke KM, Herholz K: Glucose metabolism in the caudate nuclei of patients with eating disorders measured by PET. Eur Arch Psychiatry Clin Neurosci 1991, 240:331-333.
19. Doraiswamy PM, Krishnan KR, Figiel GS, Husain MM, Boyko OB, Rockwell WJ, Ellinwood EH, Jr: A brain magnetic resonance imaging study of pituitary gland morphology in anorexia nervosa and bulimia. Biol Psychiatry 1990, 28:110-116.
20. Katzman DK, Lambe EK, Mikulis DJ, Ridgley JN, Goldbloom DS, Zipursky RB: Cerebral gray matter and white matter volume deficits in adolescent girls with anorexia nervosa. J Pediatr 1996, 129:794-803. The latest work on neuroimaging in anorexia nervosa patients.
21. Hoffman L, Halmi K: Comorbidity and course of anorexia nervosa. Child Adolesc Clin N Am 1993, 2:129-144.
22. Obarzanek E, Lesem MD, Jimerson DC: Resting metabolic rate of anorexia nervosa patients during weight gain. Am J Clin Nutr 1995, 60:666-675.
23. Kaye WH, Enright AB, Lesser S: Characteristics of eating disorders programs and common problems with third-party providers. Int J Eating Disorders 1988, 7:573-579.
24. Baran SA, Weltzin TE, Kaye WH: Low discharge weight and outcome in anorexia nervosa. Am J Psychiatry 1995, 152:1070-1072.
25. Foreyt JP, Poston WSC, Goodrick GK: Future directions in obesity and eating disorders. Addictive Behav 1996, 21:767-778. A thought provoking article that provides suggestions for future research and treatment strategies in eating disorders.